Australia markets closed

Fresh Tracks Therapeutics, Inc. (FRTX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.9100-0.0250 (-2.67%)
At close: 09:54AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-5,694
-5,694
-21,102
-39,474
-20,913
Depreciation & amortisation
41
41
30
22
10
Stock-based compensation
1,919
1,919
2,156
2,263
1,993
Change in working capital
-669
-669
-478
-571
-1,649
Accounts payable
-165
-165
-1,034
1,023
-1,677
Other working capital
-4,343
-4,343
-19,382
-36,184
-20,057
Other non-cash items
60
60
59
2,049
500
Net cash provided by operating activities
-4,343
-4,343
-19,335
-36,148
-20,034
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-47
-36
-23
Sales/maturities of investments
-
-
-
0
4,500
Net cash used for investing activities
0
0
-47
-36
4,477
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
6,569
6,569
1,196
24,006
37,977
Other financing activities
-38
-38
-55
-51
-
Net cash used provided by (used for) financing activities
6,531
6,531
1,178
32,953
38,440
Net change in cash
2,188
2,188
-18,204
-3,231
22,883
Cash at beginning of period
8,680
8,680
26,884
30,115
7,232
Cash at end of period
10,868
10,868
8,680
26,884
30,115
Free cash flow
Operating cash flow
-4,343
-4,343
-19,335
-36,148
-20,034
Capital expenditure
-
-
-47
-36
-23
Free cash flow
-4,343
-4,343
-19,382
-36,184
-20,057